For maintenance therapy Pharmaceutical compositions containing as the active ingredient an Antibody that recognizes the Human leukocyte antigen (HLA) Class I

摘要

The drug components of maintenance therapy include an antibody identifying a class of human leukocyte antigen (HLA) as the active component, a method of maintaining the post-treatment status of cancer (post-treatment status),Including the administration of an antibody for the identification of a primary HLA to a person, claim 6: the use of an antibody for the identification of a primary HLA feature, as it is the manufacture of a pharmaceutical ingredient for a treatmentMaintenance department Requirement No. 11: an antibody for the identification of primary HLA, which is characterized by being used to maintain a state achieved after treatment of a disease (for disease maintenance treatment).